2016 American Transplant Congress
Renal Allograft Outcomes with Renal Artery Angioplasty and/or Stenting in Transplant Renal Artery Stenosis.
Background: The renal allograft function and blood pressure (BP) control after renal artery angioplasty±stenting for transplant renal artery stenosis (TRAS) is unclear. We aim to…2016 American Transplant Congress
Should Renin Angiotensin Blockade Be the Mainstay of Hypertension Treatment in Kidney Donors?
Introduction: The prevalence of hypertension (HTN) in kidney donors is comparable to what is seen in the general population. How HTN in donors is treated…2016 American Transplant Congress
Landscape of Hypertension Treatment in Former Kidney Donors.
The aim of this analysis is to describe the general epidemiological features for the development of hypertension and the most frequent medical therapies prescribed in…2016 American Transplant Congress
Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
Background;Renal transplantation is the treatment of choice for individuals with end stage renal disease (ESRD).Method; This is a retrospective review of eight live related renal…2016 American Transplant Congress
An Assurance of Insurance: Should Living Kidney Donors Be Required to Have Health Insurance?
Lack of health insurance has been related lack of access to health care, poorer health, and increased mortality. In this study, we investigate sociodemographic predictors…2016 American Transplant Congress
Treatments Against Renin-Angiotensin-Aldosterone System Could Influence FGF23 and Klotho Levels in Renal Transplant Recipients.
Purpose: Angiotensin-converting enzyme inhibitor ( ACEI) and angiotensin II receptor blocker (ARB) are frequently used in post transplant hypertension. Recent trials reported that renin-angiotensin-aldosterone system…2015 American Transplant Congress
The Impact of Hypertension, Chronic Pain, and Fatigue on Long-Term Quality of Life After Living Kidney Donation
The rising prevalence of end-stage renal disease and Germany's chronic organ shortage subsequently calls more people upon to consider living kidney donation. The benefits for…2015 American Transplant Congress
Birth Weight as a Marker of Nephron Mass: Predicting Living Kidney Donor Outcomes
It has been demonstrated that low birth weights give rise to a reduction in nephron number and low glomerular size in the postnatal kidney. Oligonephropathy…2015 American Transplant Congress
Outcomes of Kidney Transplantation from Hypertensive Living Donors
Imperial College Renal and Transplant Centre, Hammersmith Hospital, London, United Kingdom.
The disparity between donor kidney availability and demand has increased utilization of kidneys from marginal living donors, including hypertensive donors. The aim of this study…2015 American Transplant Congress
Arterial Hypertension and the Use of Antihypertensive Medication in Pediatric Renal Transplant Patients: An Analysis of the CERTAIN Registry
BackgroundOur study aimed to describe the prevalence of hypertension, blood pressure (BP) control and the use of antihypertensive (AH) drugs in pediatric renal transplant patients.MethodsCasual…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- Next Page »